OVERVIEW

Chlamydia: The Silent Epidemic Course is organized by ContinuingEducation.com - OnCourse Learning Corporation and will be held from Mar 07, 2013 - Jun 28, 2019.

The target audience for this medical event is intended for multiple professions, including nurses, laboratory professionals, and physicians.

Accreditation:
Physician Continuing Education Credit
OnCourse Learning designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Physician Assistant Continuing Education Credit
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.0 hour of Category I credit for completing this program.

Summary:
In 2014, more than 1.4 million cases of Chlamydia trachomatis infection were reported to the CDC, making chlamydia the most commonly reported notifiable disease in the United States. Due to the asymptomatic nature of this infection, it’s estimated that a significant number of infected people remained undiagnosed and were not represented in the statistical data. Many healthcare providers are unfamiliar with the frequency of this infection and its potentially permanent impact on people of reproductive age. This continuing education program will update healthcare professionals’ knowledge about the diagnosis and care of patients with chlamydia.

Objectives:
The goal of this continuing education program is to update healthcare professionals’ knowledge about the care of patients with chlamydia. After studying the information presented here, you will be able to:
• Relate the pathophysiology of chlamydia infection to two negative outcomes
• List four risk factors and three signs and symptoms of chlamydia infection
• Describe four educational measures that can reduce the risk of recurrent chlamydia infections in patients of reproductive age.